Tucson, AZ 9/18/15—Protein Technologies (PTI) has reached an agreement with Peptide Solutions (PSL) in its suit against the company alleging breach of contract, breach of fiduciary duty, misappropriation of trade secrets and proprietary information, and tortious interference (see IBO 1/31/15). PTI has withdrawn the case, and PSL has dropped its counterclaims.

Mannheim, Germany 9/15/15; Cambridgeshire, UK 9/7/15—IVD firm ERBA Diagnostics Mannheim has acquired Lumora, a provider of diagnostic technology for clinical and industrial markets, for an undisclosed amount. “The acquisition of Lumora enhances our existing portfolio of instruments, test kits and reagents for clinical chemistry, microbiology, hematology, diabetes, immunology, urine chemistry, critical care and homeostasis testing,” […]

Omaha, NE 9/30/15 — Transgenomic has announced the signing of a term sheet to sell its Genetic Assays & Platforms Business Unit (GAP) to ADTEC, a Japanese supplier of instruments and reagents to the biotechnology industry. Transgenomic will receive $300,000 for existing GAP stock and inventory. The divestment is expected to reduce Transgenomic’s expenses by […]

Oberkochen, Germany 9/25/15—ZEISS Microscopy has announced a restructuring plan that includes development, production, sales and marketing. One hundred thirty jobs will be eliminated and 150 relocated. Changes will also be made at all Microscopy sites. All activities at the business’s Göttingen site except production will be transferred. Production at the site, consisting of 240 employees, […]

Earlier this year, South Korea’s Ministry of Science, ICT and Future Planning published the “Survey of Research and Development in Korea, 2013,” presenting its latest review of South Korean R&D expenditures. The country’s R&D spending is particularly notable as South Korea, at 4.15%, has the highest R&D expenditures as a percentage of GDP among Organization […]

Darmstadt, Germany 9/28/15; St. Louis, MO 9/28/15—Merck KGaA has announced that it expects to close its $17 billion acquisition of Sigma-Aldrich (see IBO 9/30/14) within the next two months. Merck had originally expected the transaction to close in the third quarter. “We are diligently working on fulfilling the EU commitments,” commented Bernd Reckmann, member of […]

Pharmaceutical companies in China have increased their investment in R&D to 6.9% of revenue in 2014 from 3.9% in 2009. This has helped them make the shift from manufacturers of active pharmaceutical ingredients to drug developers. Sino Biopharm, for example, stepped up its R&D investment sevenfold to $140 million from 2009 to 2014. This, along […]